期刊文献+

三种人群脂质代谢异常的特征 被引量:4

The Characteristics and Comparison of Lipid Metabolic Abnormity in Three Groups of Population
下载PDF
导出
摘要 目的比较糖尿病患者、冠心病患者和企业在职员工的脂质代谢异常情况。方法采用资料收集与现场实验室检测相结合的方法,获取三种人群的血脂检测情况。结果在冠心病患者中总胆固醇和甘油三酯的异常率分别为50.85%和56.91%;在糖尿病患者中分别为41.28%和46.82%;在企业员工中分别为23.58%和32.46%;肥胖和超重人群中总胆固醇异常率为43.55%,甘油三酯异常率为51.75%,均高于体质指数正常人群;腰臀比异常人群中甘油三酯异常率(46.35%)高于腰臀比正常人群(39.77%),差别有统计学意义(P<0.05)。结论三种人群的血脂代谢异常率不同,以冠心病患者最高;脂代谢异常与体质指数有一定的关系。 Objective To compare the characteristics and abnormity of lipid metabolism among three groups of population in Yangpu.Methods The data of blood lipids of three subpopulations were collected by epidemiologic investigation and experimental examination.Results The abnormal rates of total cholesterol and triglycerides were 50.85% and 56.91% in patients with coronary heart diseases;41.28% and 46.82% in patients with diabetes,23.58% and 32.46% in staffs of enterprises.The abnormal rates of total cholesterol and triglycerides were 43.55% and 51.75% in over-weight subjects,and all of them were higher than those in subjects with normal body mass index.The abnormal rate of triglycerides was significant higher in subjects with abnormal ratio of waist-hip(46.35%) than that with normal ratio(39.77%,P〈0.05).Conclusion The abnormal rate of lipids metabolism was different among three groups of population,and highest in patients with coronary heart diseases;there was some relationships between lipid metabolism and body type.
出处 《中国慢性病预防与控制》 CAS 2008年第2期184-186,共3页 Chinese Journal of Prevention and Control of Chronic Diseases
关键词 胆固醇 甘油三酯类 糖尿病 冠心病 脂代谢异常 Cholesterol Triglycerides Diabetes Coronary heart disease Lipid metabolic abnormity
  • 相关文献

参考文献6

二级参考文献15

  • 1朱喜星.现代糖尿病学[M].上海:上海医科大学出版社,2000.13-13. 被引量:2
  • 2[1]Feher M, Elkeles R.Lipid modification and coronary heart disease in type 2 diabetes:different from the general population.Heart,1999,81:10-11. 被引量:1
  • 3[2]Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adults Treatment Panel III).JAMA,2001,285:2486-2497. 被引量:1
  • 4[3]Holman R. The UKPDS: implications for the dyslipidaemic patient. Acta Diabetol,2001,38: S9-14. 被引量:1
  • 5[4]Taskinen MR, Smith U. Lipid disorders in NIDDM: implications for treatment. Journal of Internal Medicine,1998,244:361-370. 被引量:1
  • 6[5]Barnett AH.Dyslipidaemia in diabetes-A GP guide.Practitioner,2002,246:120-123. 被引量:1
  • 7[6]Betteridge, DJ. Diabetic dyslipidaemia. Diabetes Obes Metab,2000,2:S31-36. 被引量:1
  • 8[7]Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med,1996,335:1001-1009. 被引量:1
  • 9[8]Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Survival Study (4S). Lancet,1994,344:1383-1389. 被引量:1
  • 10[9]Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Eng J Med,1998,339:1349-1357. 被引量:1

共引文献46

同被引文献79

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部